文献速递儿童心血管与肾脏新生儿

胎儿重大先天性心脏缺陷妊娠的不良产科结局

Adverse Obstetric Outcomes in Pregnancies With Major Fetal Congenital Heart Defects.
PubMed 文献 · JAMA Pediatr · 2025-01-01

除胎儿大动脉转位外,所有MCHD亚型均与不良产科结局风险升高相关,Meta分析纳入10项额外研究支持该结果。

要点

  • 胎儿MCHD妊娠不良产科结局发生率22.8%,显著高于无MCHD妊娠的9.0%。
  • 子痫前期、早产(<37周)和胎儿生长受限风险均显著升高。
  • 除大动脉转位外,所有MCHD亚型均与不良产科结局风险升高相关。

核心结论

  • 胎儿MCHD妊娠的不良产科结局风险约为无MCHD妊娠的3倍(AOR 2.96,95%CI 2.49-3.53)。
  • 除胎儿大动脉转位外,所有MCHD亚型均携带更高的不良产科结局风险。

研究设计与样本

  • 丹麦队列研究,数据来自丹麦胎儿医学数据库2008年6月1日至2018年6月1日,覆盖丹麦95%以上妊娠。
  • 系统检索PubMed、Embase和Cochrane Library(建库至2024年6月1日),Meta分析纳入10项额外研究。

主要发现

  • MCHD妊娠不良产科结局发生率为22.8%,无MCHD妊娠为9.0%。
  • 子痫前期AOR 1.83(95%CI 1.33-2.51),早产<37周AOR 3.84(95%CI 3.15-4.71),胎儿生长受限AOR 3.25(95%CI 2.42-4.38)。
  • 胎儿大动脉转位AOR 1.19(95%CI 0.66-2.15),其余MCHD亚型不良产科结局风险均升高。
  • Meta分析纳入10项额外研究,结果支持上述发现。

关键数值与推荐

  • 主要结局为复合不良产科结局:子痫前期、早产、胎儿生长受限或胎盘早剥。
  • 采用广义估计方程计算调整OR,调整母亲BMI、年龄、吸烟和分娩年份。
  • Meta分析采用随机效应模型合并各MCHD亚型与不良产科结局的效应量。

临床怎么用

  • 对胎儿MCHD妊娠(除大动脉转位外)应视为不良产科结局高风险,加强产科监测与咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Understanding the risk profile of obstetric complications in pregnancies with fetal major congenital heart defects (MCHDs) is crucial for obstetric counseling and care. OBJECTIVE: To investigate the risk of placenta-related adverse obstetric outcomes in pregnancies complicated by fetal MCHDs. DESIGN, SETTING, AND PARTICIPANTS: This cohort study retrieved data from June 1, 2008, to June 1, 2018, from the Danish Fetal Medicine Database, which includes comprehensive data on more than 95% of all pregnancies in Denmark since the database was instituted in 2008. All singleton pregnancies that resulted in a live-born child after 24 weeks' gestation without chromosomal aberrations were included. A systematic search of the literature was performed in PubMed, Embase, and the Cochrane Library from inception to June 1, 2024, to compile existing knowledge and data on adverse obstetric outcomes among MCHD subtypes. EXPOSURE: Fetal MCHDs including 1 of 11 subtypes. MAIN OUTCOMES AND MEASURES: The primary outcome was a composite adverse obstetric outcome defined as preeclampsia, preterm birth, fetal growth restriction, or placental abruption. Secondary outcomes consisted of each adverse obstetric event. Adjusted odds ratios (AORs) were computed using generalized estimating equations adjusted for maternal body mass index, age, smoking, and year of delivery. Meta-analyses were conducted using random-effects models to pool effect sizes for each MCHD subtype and adverse obstetric outcome. RESULTS: A total of 534 170 pregnancies were included in the Danish cohort, including 745 with isolated fetal MCHDs (median [IQR] maternal age, 29.0 [26.0-33.0] years) and 533 425 without MCHDs (median [IQR] maternal age, 30.0 [26.0-33.0] years). Pregnancies with fetal MCHDs exhibited a higher rate of adverse obstetric outcomes at 22.8% compared with 9.0% in pregnancies without fetal MCHDs (AOR, 2.96; 95% CI, 2.49-3.53). Preeclampsia (AOR, 1.83; 95% CI, 1.33-2.51), preterm birth at less than 37 weeks (AOR, 3.84; 95% CI, 3.15-4.71), and fetal growth restriction (AOR, 3.25; 95% CI, 2.42-4.38) occurred significantly more frequently in pregnancies with MCHDs. Except for fetal transposition of the great arteries (AOR, 1.19; 95% CI, 0.66-2.15), all MCHD subtypes carried a greater risk of adverse obstetric outcomes. The meta-analysis included 10 additional studies that supported these results. CONCLUSIONS AND RELEVANCE: These findings suggest that nearly 1 in 4 women expecting a child with an MCHD, except transposition of the great arteries, may be at high risk of adverse obstetric outcomes.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Hedermann G, Hedley PL, Gadsbøll K, et al. Adverse Obstetric Outcomes in Pregnancies With Major Fetal Congenital Heart Defects. JAMA Pediatr. 2025. PMID: 39680388. doi:10.1001/jamapediatrics.2024.5073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。